Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,622 across all filing types
Latest filing 2022-03-11 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
天域生态股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the company regarding abnormal stock price fluctuations over three consecutive trading days, referencing regulatory rules from the Shanghai Stock Exchange. It includes details about the company's investigation into the cause, confirmation of no undisclosed material information, risk warnings to investors, and a statement from the board. The document does not contain financial statements or detailed financial data but serves as a regulatory disclosure about stock price volatility and related risks. This type of document fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-03-11 Chinese
天域生态关于控股股东所持股份质押展期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the extension of a pledge of shares held by the controlling shareholder. It details the number of shares pledged, the pledge period extension, and the impact on the company. There are no financial statements or detailed financial performance data. The document is a formal disclosure about share pledge extension, which relates to capital structure but is not a financing update per se. It is not a full financial report, earnings release, or management report. It is a regulatory announcement about share pledge status, fitting best under Regulatory Filings (RNS). The document length is short (2338 characters), and it is a specific announcement rather than a report or presentation.
2022-03-11 Chinese
控股股东、实际控制人关于《天域生态环境股份有限公司股票交易异常波动的问询函》的回复
Regulatory Filings
2022-03-11 Chinese
天域生态关于部分回复上海证券交易所问询函的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Tianyu Ecological Environment Co., Ltd. responding to an inquiry letter from the Shanghai Stock Exchange regarding an external investment transaction. It discusses the audit and evaluation procedures, funding sources, risks related to the transaction, debt details of the target company, shareholder shareholding changes, and business risks. The document includes extensive financial data, risk disclosures, and operational details related to a significant investment transaction. It is not a full annual or quarterly report, nor a simple announcement of a report publication. It is not a transcript, nor a remuneration or governance report. The content focuses on a capital investment transaction, including financing arrangements, risks, and impact on liquidity and solvency. Therefore, the document fits best into the category of Capital/Financing Update (CAP).
2022-03-09 Chinese
天域生态关于收到上海证券交易所问询函延期回复的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (640 characters) from a company regarding the receipt of an inquiry letter from the Shanghai Stock Exchange and the company's intention to delay its reply. It does not contain any financial data, detailed report content, or results. It is an update on regulatory communication and compliance with disclosure requirements. The document is not a full report, financial statement, or management discussion. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about the inquiry and delay in response.
2022-03-01 Chinese
天域生态关于变更办公地址及投资者联系方式的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (560 characters) regarding a change in the company's office address and investor contact information. It includes a statement from the board ensuring the accuracy of the announcement. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report being attached or published. The content is purely informational about administrative changes. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-03-01 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.